Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
9.54
+0.03 (0.32%)
Dec 31, 2024, 4:00 PM EST - Market closed

Company Description

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon plc
Haleon logo
Country United Kingdom
Founded 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 25,408
CEO Brian McNamara

Contact Details

Address:
The Heights, Building 5, First Floor
Weybridge, KT13 0NY
United Kingdom
Phone 44 1932 822000
Website haleon.com

Stock Details

Ticker Symbol HLN
Exchange NYSE
Fiscal Year January - December
Reporting Currency GBP
CIK Code 0001900304
CUSIP Number 405552100
ISIN Number US4055521003
SIC Code 2844

Key Executives

Name Position
Brian McNamara Chief Executive Officer
Dawn Allen Chief Financial Officer
Sonya Ghobrial Head of Investor Relations

Latest SEC Filings

Date Type Title
Dec 31, 2024 6-K Report of foreign issuer
Dec 19, 2024 6-K Report of foreign issuer
Dec 13, 2024 6-K Report of foreign issuer
Dec 11, 2024 6-K Report of foreign issuer
Dec 11, 2024 6-K Report of foreign issuer
Dec 10, 2024 6-K Report of foreign issuer
Dec 5, 2024 6-K Report of foreign issuer
Nov 29, 2024 6-K Report of foreign issuer
Nov 27, 2024 6-K Report of foreign issuer
Nov 26, 2024 6-K Report of foreign issuer